Last modified: January 10, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Pharmaceutical
- Biotech & Life Sciences
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
About Tarix Pharmaceuticals
Tarix Pharmaceuticals is a pharmaceutical development company focused on unmet needs in Oncology, HIV, and other indications. Tarix’s lead compound, TXA127, is currently in a Phase II clinical trial for the treatment and prevention of thrombocytopenia (reduced platelet count) associated with cancer chemotherapy, and a Phase I clinical trial to increase the CD4 counts in AIDS patients maintained on multi-drug therapy (HAART).
This compound is also being investigated for use in stem cell transplantation, chemotherapy induced anemia, and for the treatment of illness following radiation exposure.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| Tarix Pharmaceuticals Job Trends | Tarix Pharmaceuticals Jobs |
Loading web traffic statistics. Please wait...
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| Tarix Pharmaceuticals has been added to the Ecosystem. |